Delivery Order SPE2DE24DA017-SPE2D625F2FGC
Award Date 8/29/25
Potential Completion Date 9/4/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Arthrex Inc., a leading provider of minimally invasive orthopedic medical technologies, was awarded a fixed-price delivery order valued at $3,029.40 by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025, for the ACP MAX PRP System with ACDA. The delivery order, which is not set-aside for any specific business category, has an ultimate completion date of July 29, 2025, and will be performed in Naples, Florida. This award represents a task order under Arthrex's broader Indefinite...
- Arthrex Inc. has been awarded a delivery order valued at $3,635.28 by the Defense Logistics Agency's Medical Supply Chain for an ACP MAX PRP System with ACDA functionality. The contract, issued on August 29, 2025, carries a fixed-price structure with economic price adjustment provisions and is scheduled for completion by September 4, 2025. This delivery order represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, a $471...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $1,817.64 delivery order from the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, for an ACP MAX PRP (Autologous Conditioned Plasma Maximum Platelet-Rich Plasma) System with Autologous Conditioned Plasma technology. This fixed-price contract with economic price adjustment provisions is set to conclude by August 18, 2025, and represents a task order under Arthrex's larger Indefinite...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,029.40 on August 27, 2025, for the ACP MAX PRP System with ACDA (autologous conditioned plasma). This fixed-price delivery order with economic price adjustment is scheduled for completion by September 2, 2025, and represents performance under Arthrex's larger indefinite delivery contract with the Defense Logistics Agency's Medical Supply Chain. The order...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $7,270.56 on September 12, 2025, for the ACP MAX PRP System with ACDA. This fixed-price delivery order with economic price adjustment falls under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for supplying medical products to Department of Defense and Department of Veterans Affairs...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $20,710.80 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain for the ACP MAX PRP System (OUS/EU). Awarded on September 5, 2025, with an ultimate completion date of September 10, 2025, this delivery order is issued under a larger indefinite delivery contract (IDC SPE2DE24D0020) valued at $471 million and running through September 1, 2029. The contract includes economic...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, received a delivery order valued at $1,211.76 from the Defense Logistics Agency's Medical Supply Chain on June 6, 2025. The order, designated as contract 4568471533 for an ACP MAX PRP System with ACDA (Autologous Conditioned Plasma with Advanced Concentrated Data Analysis), is structured as a fixed-price delivery order with economic price adjustment provisions and carries a completion date of June...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,817.64 fixed-price delivery order to Arthrex Inc. on June 2, 2025, with a completion date of June 5, 2025. This order falls under Arthrex's existing indefinite delivery contract (IDC SPE2DE24D0020) valued at $471.0 million and running through September 1, 2029. The delivery order is for ACP MAX PRP System components with ACDA integration, which Arthrex will supply to the Naples, Florida location. The award was not set aside...
- Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $2,475 for the Arthrex ACP Double Syringe System from the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment capability was awarded on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract represents no set-aside designation,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $4,356.00 for the Arthrex ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment is scheduled for completion by June 24, 2025, and represents a specific task order issued under Arthrex's larger indefinite delivery contract (SPE2DE24D0020) with the Defense...